F H Drake
- Molecular Biology top 5%
- Oncology top 5%
- Toxicology top 0.5%
- Organic Chemistry top 10%
- Cell Biology top 10%
- Co-authors
- Christopher K. MirabelliMichael R. MatternRichard WoessnerRandall K. JohnsonStanley T. CrookeP. N. RaoK. B. TanGary J. Gorbsky
- Topics
- Cancer therapeutics and mechanisms (8 papers)Bone Metabolism and Diseases (4 papers)Bone health and treatments (3 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Controlled Release
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
F H Drake
15 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 1.4k
- Oncology 669
- Toxicology 258
- Organic Chemistry 192
- Cell Biology 117
Countries citing papers authored by F H Drake
This map shows the geographic impact of F H Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F H Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F H Drake more than expected).
Fields of papers citing papers by F H Drake
This network shows the impact of papers produced by F H Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F H Drake. The network helps show where F H Drake may publish in the future.
Co-authorship network of co-authors of F H Drake
This figure shows the co-authorship network connecting the top 25 collaborators of F H Drake. A scholar is included among the top collaborators of F H Drake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F H Drake. F H Drake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 62 | |
| 3 | 37 | |
| 4 | 21 | |
| 5 | 52 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 16 | |
| 9 | 152 | |
| 10 | Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells. | 6 |
| 11 | Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. | 409 |
| 12 | Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II. | 88 |
| 13 | 216 | |
| 14 | In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. | 147 |
| 15 | 63 | |
| 16 | 256 |
About F H Drake
F H Drake is a scholar working on Rheumatology, Oncology and Molecular Biology, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Bone Metabolism and Diseases (4 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Toxicology (258 citations), Oncology (669 citations) and Molecular Biology (1.4k citations). F H Drake has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Christopher K. Mirabelli, Michael R. Mattern, Richard Woessner, Randall K. Johnson, Stanley T. Crooke, P. N. Rao, K. B. Tan, Gary J. Gorbsky, Thomas D.Y. Chung and G A Hofmann. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.